Lipocine
LPCN
LPCN
18 hedge funds and large institutions have $1.67M invested in Lipocine in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
7
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Renaissance Technologies
New York
|
$110K |
| 2 |
Morgan Stanley
New York
|
$1.82K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$711K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
$75.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
$2.13K |
